Results 11 to 20 of about 236,415 (301)

Hemolytic Anemia of Malignancy: A Case Study Involving Signet Ring Cell Metastatic Breast Cancer with Severe Microangiopathic Hemolytic Anemia [PDF]

open access: yesCase Reports in Oncology, 2019
Hemolytic anemia in the setting of malignancy is a rare manifestation of paraneoplastic syndrome with significant morbidity. Here we discuss a case involving metastatic breast cancer presenting with severe hemolytic anemia and renal failure secondary to ...
Eric H. Lee   +3 more
doaj   +2 more sources

Traumatic Hemolytic Anemia after Valve Surgery: a Case Report [PDF]

open access: yesFolia Medica, 2020
Hemolytic anemia is an uncommon complication after mitral valve repair. We present a case of a 55-year-old man who presented with post-operative hemolytic anemia after mitral valve repair with prosthetic ring.
Feridoun Sabzi   +2 more
doaj   +4 more sources

Immune hemolytic anemia in a patient with tuberculous lymphadenitis

open access: yesJournal of Global Infectious Diseases, 2011
Anemia in tuberculosis is usually anemia of chronic disease. Severe hemolytic anemia is exceedingly rare in tuberculosis patients. We report a patient diagnosed with tubercular lymphadenitis complicated by Coomb′s positive hemolytic anemia.
Manjunath Nandennavar   +3 more
doaj   +2 more sources

Acute Brucellosis Presenting as an Autoimmune Hemolytic Anemia

open access: yesCase Reports in Infectious Diseases, 2018
Brucellosis is one of the most widespread zoonosis in the world. Hematological complications in brucellosis usually present as mild anemia, leukopenia, or pancytopenia. Autoimmune hemolytic anemia in brucellosis is rarely reported.
Durga Shankar Meena   +3 more
doaj   +2 more sources

Hemolytic anemia

open access: yesMediterranean Journal of Hematology and Infectious Diseases, 2014
Summary: Hemolytic anemia is a collection of diseases resulting from an exaggeration of the lysis of red blood cells. Hemolysis can be caused by extravacular aggression by drugs or other toxic or by antibodies againt red blood cell.
JAMILA ELHOUDZI
doaj   +1 more source

Case report: Vitamin B12 deficiency-associated hemolytic anemia [PDF]

open access: yesFrontiers in Hematology
Vitamin B12 deficiency is commonly known to cause hematological, neurological, and gastrointestinal disturbances including anemia, pancytopenia, sub-acute combined degeneration, and glossitis, among others.
Chiranjeevi Sainatham   +7 more
doaj   +2 more sources

The challenge of microangiopathic hemolytic anemia

open access: yesIraqi Journal of Hematology, 2017
Microangiopathic hemolytic anemia (MAHA) is a Coomb's-negative hemolytic anemia characterized by red cell fragmentation (schistocytes). Thrombotic microangiopathy anemia, including thrombotic thrombocytopenia and hemolytic-uremic syndrome, malignant ...
Hassanain Hani Hassan   +1 more
doaj   +2 more sources

Venetoclax as a trigger for autoimmune hemolytic anemia in secondary acute myeloid leukemia: A case report [PDF]

open access: yesSAGE Open Medical Case Reports
Venetoclax, a BCL-2 inhibitor used in chronic lymphocytic leukemia and acute myeloid leukemia, has been rarely associated with autoimmune hemolytic anemia, mostly in chronic lymphocytic leukemia.
Karima Benallaoua   +4 more
doaj   +2 more sources

Non-immune Hemolysis in Gaucher Disease and Review of the Literature Eliyakim Hershkop, Idan Bergman, Alina Kurolap, Najib Dally, and Hagit Baris Feld

open access: yesRambam Maimonides Medical Journal, 2021
Gaucher disease (GD) is an autosomal recessive disease characterized by the buildup of glucocerebrosides in macrophages, resulting in the formation of “Gaucher cells.” These cells predominantly infiltrate the liver, spleen, and bone marrow leading to ...
Eliyakim Hershkop   +4 more
doaj   +1 more source

Hemolytic anemia caused by alectinib, an Anaplastic Lymphoma Kinase (ALK) inhibitor: A case report

open access: yesCurrent Problems in Cancer: Case Reports, 2022
Background: Anaplastic Lymphoma Kinase (ALK) inhibitors are tyrosine kinase inhibitors used as molecular-targeted therapy for non-small cell lung cancers (NSCLC) harbouring ALK translocations.
Robina Aerts   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy